Additionally, anti-PD1 antibody may increase migration of NK cells toward MM targets and enhances immune complex formation between NK cells and PD-L1–bearing tumor cells [40], which may improve treatment efficacy of NK cells in vivo. Here, CD274 is linked to Miyoshi myopathy.